Page 28 - Insulet Omnipod News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Insulet omnipod. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Insulet Omnipod Today - Breaking & Trending Today

Insulet Co. (NASDAQ:PODD) Short Interest Down 19.6% in April

Insulet Co. (NASDAQ:PODD – Get Rating) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 3,900,000 shares, a drop of 19.6% from the March 31st total of 4,850,000 shares. Based on an average trading volume of 828,000 shares, the days-to-cover […] ....

New York , United States , Raymond James , Charles Alpuche , Wayded Mcmillan , Insulet Corp , American National Bank , Lindbrook Capital , Insulet Co , First Manhattan Co , Heritage Wealth Management , Wolfe Research , Morgan Stanley , Get Rating , National Bank , Wealth Management , Omnipod System , Insulet Daily , Nasdaq Podd ,

Insulet (PODD) Set to Announce Quarterly Earnings on Thursday

Insulet (NASDAQ:PODD – Get Rating) will be issuing its quarterly earnings data after the market closes on Thursday, May 4th. Analysts expect the company to announce earnings of $0.09 per share for the quarter. Insulet has set its FY 2023 guidance at EPS and its Q1 2023 guidance at EPS.Investors that are interested in participating […] ....

Wayded Mcmillan , Robertw Baird , Charles Alpuche , Insulet Corp , B Riley Wealth Advisors Inc , Pathstone Family Office , Wealthfront Advisers , Toroso Investments , Walleye Capital , Insulet Company Profile , Get Rating , Family Office , Wealth Advisors , Omnipod System , Insulet Daily , Nasdaq Podd ,

Insulet Announces FDA Clearance of Omnipod GO, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes

25.04.2023 - Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced the FDA clearance of its latest innovation, Omnipod GO, an insulin delivery device . ....

United States , Jim Hollingshead , Insulet Corporation , Business Wire , Chief Executive , Omnipod Insulin Management System , Insulin Delivery System , Insulet Stock ,

Insulet (NASDAQ:PODD) PT Raised to $350.00

Insulet (NASDAQ:PODD – Get Rating) had its target price lifted by BTIG Research from $340.00 to $350.00 in a research report released on Monday morning, The Fly reports. The firm currently has a buy rating on the medical instruments supplier’s stock. A number of other equities research analysts have also weighed in on the company. […] ....

New York , United States , Robertw Baird , Wayded Mcmillan , Lombard Odier Scm , Charles Alpuche , Raymond James , Heritage Wealth Management , Wolfe Research , Insulet Corp , First Manhattan Co , Huntington National Bank , Securities Exchange Commission , Get Rating , Exchange Commission , National Bank , Wealth Management , Compagnie Lombard Odier , Omnipod System , Insulet Daily , Nasdaq Podd , Boost Price Target , Btig Research ,

Insulet (NASDAQ:PODD) Price Target Increased to $342.00 by Analysts at Stifel Nicolaus

Insulet (NASDAQ:PODD – Get Rating) had its price objective lifted by Stifel Nicolaus from $300.00 to $342.00 in a report published on Thursday, The Fly reports. The brokerage currently has a hold rating on the medical instruments supplier’s stock. Other analysts have also issued reports about the company. Morgan Stanley boosted their target price on […] ....

Charles Alpuche , Stifel Nicolaus , Wayded Mcmillan , Lord Abbett , Scout Investments Inc , Moneta Group Investment Advisors , Insulet Corp , Clearbridge Investments , Wolfe Research , Morgan Stanley , Norges Bank , Get Rating , Trading Down , Group Investment Advisors , Scout Investments , Omnipod System , Insulet Daily , Nasdaq Podd , Boost Price Target ,